Effect of Ciclesonide (320 Mcg/Day) vs Fluticasone Propionate (375 Mcg/Day) vs. Placebo on Short-term Linear Growth Rate and HPA-axis Function in Prepubertal Children With Mild Asthma.
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Ciclesonide; Fluticasone propionate
- Indications Asthma
- Focus Adverse reactions; Registrational
- 04 May 2012 Additional lead trial investigator (Soren Pedersen) identified as reported by ClinicalTrials.gov.
- 04 May 2012 Company (Takeda Global Research and Development Center) added to the associations field as reported by ClinicalTrials.gov record.
- 05 Nov 2005 New trial record.